Nathan Rice
Stock Analyst at Goldman Sachs
(3.84)
# 683
Out of 4,415 analysts
27
Total ratings
50%
Success rate
10.62%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Reiterates: Overweight | $53 → $59 | $44.32 | +31.99% | 3 | May 3, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $55.26 | +33.91% | 2 | May 2, 2024 | |
| BFC Bank First | Maintains: Neutral | $90 → $87 | $81.42 | +6.85% | 3 | Apr 18, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $293.44 | -23.32% | 9 | Feb 2, 2024 | |
| BY Byline Bancorp | Maintains: Overweight | $27 → $28 | $22.80 | +22.81% | 2 | Jan 30, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $79.99 | +5.01% | 1 | Jan 10, 2024 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $33 → $36 | $32.39 | +11.15% | 1 | Aug 16, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $13.65 | -34.07% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $487.93 | -10.85% | 2 | Jul 21, 2022 | |
| CI Cigna | Initiates: Neutral | n/a | $338.06 | - | 1 | Dec 14, 2021 | |
| CNC Centene | Initiates: Neutral | n/a | $74.15 | - | 1 | Dec 14, 2021 | |
| OSBC Old Second Bancorp | Initiates: Overweight | n/a | $14.24 | - | 1 | Dec 19, 2019 |
Merchants Bancorp
May 3, 2024
Reiterates: Overweight
Price Target: $53 → $59
Current: $44.32
Upside: +31.99%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $55.26
Upside: +33.91%
Bank First
Apr 18, 2024
Maintains: Neutral
Price Target: $90 → $87
Current: $81.42
Upside: +6.85%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $293.44
Upside: -23.32%
Byline Bancorp
Jan 30, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $22.80
Upside: +22.81%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $79.99
Upside: +5.01%
First Mid Bancshares
Aug 16, 2023
Maintains: Overweight
Price Target: $33 → $36
Current: $32.39
Upside: +11.15%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $13.65
Upside: -34.07%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $487.93
Upside: -10.85%
Cigna
Dec 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $338.06
Upside: -
Centene
Dec 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $74.15
Upside: -
Old Second Bancorp
Dec 19, 2019
Initiates: Overweight
Price Target: n/a
Current: $14.24
Upside: -